TWI250985B - Method for preparing sterically hindered phosphoramidates - Google Patents
Method for preparing sterically hindered phosphoramidates Download PDFInfo
- Publication number
- TWI250985B TWI250985B TW089119261A TW89119261A TWI250985B TW I250985 B TWI250985 B TW I250985B TW 089119261 A TW089119261 A TW 089119261A TW 89119261 A TW89119261 A TW 89119261A TW I250985 B TWI250985 B TW I250985B
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- oxygen
- diaryl
- chlorophosphate
- solvent
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 36
- 150000008298 phosphoramidates Chemical class 0.000 title abstract 2
- -1 diaryl chlorophosphate Chemical compound 0.000 claims abstract description 27
- 239000002253 acid Substances 0.000 claims abstract description 13
- 239000000010 aprotic solvent Substances 0.000 claims abstract description 11
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229910017464 nitrogen compound Inorganic materials 0.000 claims abstract description 7
- 150000002830 nitrogen compounds Chemical class 0.000 claims abstract description 7
- 150000002391 heterocyclic compounds Chemical class 0.000 claims abstract description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 28
- 229910052760 oxygen Inorganic materials 0.000 claims description 27
- 239000001301 oxygen Substances 0.000 claims description 27
- 125000003118 aryl group Chemical group 0.000 claims description 22
- JZTPOMIFAFKKSK-UHFFFAOYSA-N O-phosphonohydroxylamine Chemical compound NOP(O)(O)=O JZTPOMIFAFKKSK-UHFFFAOYSA-N 0.000 claims description 21
- 125000000217 alkyl group Chemical group 0.000 claims description 21
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical group CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 15
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 15
- 229910052717 sulfur Inorganic materials 0.000 claims description 15
- 239000011593 sulfur Substances 0.000 claims description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical group ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 12
- 230000009477 glass transition Effects 0.000 claims description 12
- 229910052736 halogen Inorganic materials 0.000 claims description 11
- 150000002367 halogens Chemical class 0.000 claims description 11
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 claims description 8
- 235000019402 calcium peroxide Nutrition 0.000 claims description 8
- 230000002079 cooperative effect Effects 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N argon Substances [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- FVZVCSNXTFCBQU-UHFFFAOYSA-N phosphanyl Chemical group [PH2] FVZVCSNXTFCBQU-UHFFFAOYSA-N 0.000 claims description 3
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 2
- JKPAIQYTAZUMKI-UHFFFAOYSA-N N[P] Chemical compound N[P] JKPAIQYTAZUMKI-UHFFFAOYSA-N 0.000 claims description 2
- 229910052786 argon Inorganic materials 0.000 claims description 2
- 239000000052 vinegar Substances 0.000 claims description 2
- 235000021419 vinegar Nutrition 0.000 claims description 2
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical group CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 claims 2
- JVVKBEGGHBHTDZ-UHFFFAOYSA-N 3-chloro-1,5-dihydro-2,4,3$l^{5}-benzodioxaphosphepine 3-oxide Chemical compound C1OP(Cl)(=O)OCC2=CC=CC=C21 JVVKBEGGHBHTDZ-UHFFFAOYSA-N 0.000 claims 1
- UZFMOKQJFYMBGY-UHFFFAOYSA-N 4-hydroxy-TEMPO Chemical compound CC1(C)CC(O)CC(C)(C)N1[O] UZFMOKQJFYMBGY-UHFFFAOYSA-N 0.000 claims 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- YCWSUKQGVSGXJO-NTUHNPAUSA-N nifuroxazide Chemical group C1=CC(O)=CC=C1C(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 YCWSUKQGVSGXJO-NTUHNPAUSA-N 0.000 claims 1
- 239000003586 protic polar solvent Substances 0.000 claims 1
- SQQWBSBBCSFQGC-JLHYYAGUSA-N ubiquinone-2 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O SQQWBSBBCSFQGC-JLHYYAGUSA-N 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 9
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 abstract description 3
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 abstract description 3
- 239000000292 calcium oxide Substances 0.000 abstract description 3
- FBTNFIJWMLUPPN-UHFFFAOYSA-N 1,4-bis[bis(2,6-dimethylphenoxy)phosphoryl]piperazine Chemical compound CC1=CC=CC(C)=C1OP(=O)(N1CCN(CC1)P(=O)(OC=1C(=CC=CC=1C)C)OC=1C(=CC=CC=1C)C)OC1=C(C)C=CC=C1C FBTNFIJWMLUPPN-UHFFFAOYSA-N 0.000 abstract 1
- WXCXJSOCIOHPLT-UHFFFAOYSA-N 2-[chloro-(2,6-dimethylphenoxy)phosphoryl]oxy-1,3-dimethylbenzene Chemical compound CC1=CC=CC(C)=C1OP(Cl)(=O)OC1=C(C)C=CC=C1C WXCXJSOCIOHPLT-UHFFFAOYSA-N 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 description 16
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- 125000005110 aryl thio group Chemical group 0.000 description 14
- 125000002947 alkylene group Chemical group 0.000 description 11
- 150000001412 amines Chemical class 0.000 description 11
- 125000003545 alkoxy group Chemical group 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 4
- 125000004414 alkyl thio group Chemical group 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000002923 oximes Chemical class 0.000 description 3
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- WCKVFZXCNOYOSE-UHFFFAOYSA-N P1(OCC2=CC(=CC=C2)CO1)(=O)Cl Chemical compound P1(OCC2=CC(=CC=C2)CO1)(=O)Cl WCKVFZXCNOYOSE-UHFFFAOYSA-N 0.000 description 2
- 150000001260 acyclic compounds Chemical class 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 125000002877 alkyl aryl group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- ITVPBBDAZKBMRP-UHFFFAOYSA-N chloro-dioxido-oxo-$l^{5}-phosphane;hydron Chemical compound OP(O)(Cl)=O ITVPBBDAZKBMRP-UHFFFAOYSA-N 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 125000000547 substituted alkyl group Chemical group 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- HORKYAIEVBUXGM-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoxaline Chemical compound C1=CC=C2NCCNC2=C1 HORKYAIEVBUXGM-UHFFFAOYSA-N 0.000 description 1
- RNFJDJUURJAICM-UHFFFAOYSA-N 2,2,4,4,6,6-hexaphenoxy-1,3,5-triaza-2$l^{5},4$l^{5},6$l^{5}-triphosphacyclohexa-1,3,5-triene Chemical compound N=1P(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP=1(OC=1C=CC=CC=1)OC1=CC=CC=C1 RNFJDJUURJAICM-UHFFFAOYSA-N 0.000 description 1
- SCVJRXQHFJXZFZ-KVQBGUIXSA-N 2-amino-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purine-6-thione Chemical compound C1=2NC(N)=NC(=S)C=2N=CN1[C@H]1C[C@H](O)[C@@H](CO)O1 SCVJRXQHFJXZFZ-KVQBGUIXSA-N 0.000 description 1
- MJYFVDNMTKLGTH-UHFFFAOYSA-N 4-bromo-6-(3,4-dichlorophenyl)sulfanyl-1-[[4-(dimethylcarbamoyl)phenyl]methyl]indole-2-carboxylic acid Chemical group BrC1=C2C=C(N(C2=CC(=C1)SC1=CC(=C(C=C1)Cl)Cl)CC1=CC=C(C=C1)C(N(C)C)=O)C(=O)O MJYFVDNMTKLGTH-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- LONQTZORWVBHMK-UHFFFAOYSA-N [N].NN Chemical class [N].NN LONQTZORWVBHMK-UHFFFAOYSA-N 0.000 description 1
- JIJTZGFLZBZVQJ-UHFFFAOYSA-N [Ru].NN Chemical group [Ru].NN JIJTZGFLZBZVQJ-UHFFFAOYSA-N 0.000 description 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Natural products C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 229910001570 bauxite Inorganic materials 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 239000003063 flame retardant Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- NOVHEGOWZNFVGT-UHFFFAOYSA-N hydrazine Chemical group NN.NN NOVHEGOWZNFVGT-UHFFFAOYSA-N 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- DAZXVJBJRMWXJP-UHFFFAOYSA-N n,n-dimethylethylamine Chemical compound CCN(C)C DAZXVJBJRMWXJP-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 239000005365 phosphate glass Substances 0.000 description 1
- 125000001095 phosphatidyl group Chemical group 0.000 description 1
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229920005992 thermoplastic resin Polymers 0.000 description 1
- 125000004149 thio group Chemical group *S* 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/24—Esteramides
- C07F9/2454—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
- C07F9/2458—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of aliphatic amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
- C07F9/6518—Five-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Paper (AREA)
Abstract
Description
1250985 A7 __ B7 五、發明說明(1 ) 相關申請案之參考 本案主張臨時申請案序號6 0 / 1 3 5 7 5 5之優先 權。 本發明背景 本發明係關於位阻之胺基磷酸酯的製備,特別是由氮 系鹼與氯磷酸二芳酯製得。 以位阻之胺基磷酸酯,如,N,N > 一二〔二一(2 ’ 6 —二甲苯氧基)膦基〕六氫吡畊(下文中有時稱爲 X P P )作爲合成樹脂(特別是熱塑性樹脂,如聚碳酸酯 ’ A B S樹脂及其摻合物)的難燃添加劑已被發現具有特 別的優點,包括所得摻合物具有改良的高溫安定性。例如 可參考U S 5 9 7 3 0 4 1與同一申請人之申請案序號 09/235679 與 0 9/ 364915。 XP P及其同系物係由氯磷酸二芳酯(如氯磷酸二( 2 ’ 6 -二甲苯酯))與含兩個鹼性N - Η基團之雜環化 合物(如六氫吡畊)反應而便利地製得。根據Talley ,J. Chem. Eng· Data, 33,22 1 -222 ( 1 983 )之先前技藝,該反應 係於作爲溶劑之氯仿中與作爲酸接受劑之三乙胺存在時進 行。三乙胺之用量爲化學計量或過量,其與副產物氯化氫 反應以使反應完成。1250985 A7 __ B7 V. INSTRUCTIONS (1) Reference to the relevant application This case claims the priority of the provisional application number 6 0 / 1 3 5 7 5 5. BACKGROUND OF THE INVENTION This invention relates to the preparation of sterically hindered aminophosphates, particularly from nitrogen bases and diaryl chlorophosphates. A sterically hindered amino phosphate such as N,N > bis[2-(2'6-xyloxy)phosphino]hexahydropyrazine (hereinafter sometimes referred to as XPP) as a synthetic resin Flammable additives (especially thermoplastic resins such as polycarbonate 'ABS resins and blends thereof) have been found to have particular advantages, including improved blending of the high temperature stability. For example, reference is made to U S 5 9 7 3 0 4 1 and the same applicant's application numbers 09/235679 and 0 9/364915. XP P and its homologues are diaryl chlorophosphates (such as bis(2'6-xylylene) chlorophosphate) and heterocyclic compounds containing two basic N-indenyl groups (such as hexahydropyrazine). It is conveniently prepared by reaction. According to the prior art of Talley, J. Chem. Eng. Data, 33, 22 1 -222 (1 983), the reaction is carried out in the presence of chloroform as a solvent and triethylamine as an acid acceptor. The amount of triethylamine used is stoichiometric or excessive, which reacts with the by-product hydrogen chloride to complete the reaction.
Talley的文獻說明數個同系化合物的製備,包括那些 衍生自苯甲胺,環己胺,苯胺,乙二胺,對苯二胺與六氫 口比哄_氮系化合物者。其所報告的產率可筒達9 0 % (與 本紙張尺度適用中國國家標準(CNS)A4規格(21〇 x 297公釐) (請先閱讀背面之注意事項再填寫本頁) F-裝-----r---訂---------線』 經濟部智慧財產局員工消費合作社印製 -4- 250985 A7 _____B7__ 五、發明說明(2 ) 苯胺反應者),及低至6 1 % (與對苯二胺反應者)。六 氫吡畊以只有6 8 %的產率製得X P p,爲最低的數個之 若要使X P P爲業界可用的難燃添加劑,需要顯著地 改善其產率。同時於產業規模中也要降低具有相當毒性之 溶劑氯仿以及化學計量之三乙胺的使用。 所以有興趣硏發以較無害的原料來製備X P P及其同 系物的高產率方法。 本發明簡述 本發明發現較不貴的鹼性無機化 於製備X P P及其同系物時作爲酸接 少一種偶極非質子溶劑,全部或部分 率高且反應迅速。 因此本發明一具體例爲製備位阻 包括令位阻氯磷酸二芳酯與含至少兩 鹼性氮系化合物接觸,且係於作爲酸 至少一種偶極非質子溶劑存在時進行^ 本發明另一具體例爲製備位阻胺 括令氯磷酸二芳酯與含至少兩個鹼性 系化合物接觸,且係於作爲酸接受劑 種偶極非質子溶劑存在時進行,該胺 溫度爲至少約0 °C,較好爲至少約1 2 〇 t:。 請 先 閱 讀 背 之 注 意 項Talley's literature describes the preparation of several homologous compounds, including those derived from benzylamine, cyclohexylamine, aniline, ethylenediamine, p-phenylenediamine and hexahydrogen hydrazine-nitrogen compounds. The reported yield can reach 90% (this is the same as the Chinese National Standard (CNS) A4 specification (21〇x 297 mm). (Please read the back note and fill out this page) F-Install -----r---订----------" Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing -4- 250985 A7 _____B7__ V. Invention description (2) Aniline responders), and As low as 61% (reactive with p-phenylenediamine). Hexahydropyrazine produces X P p in a yield of only 68%, which is the lowest number. To make X P P an industrially available flame retardant additive, it is necessary to significantly improve its yield. At the same time, the use of the relatively toxic solvent chloroform and the stoichiometric amount of triethylamine is also reduced in the industrial scale. Therefore, it is of interest to develop high yield methods for the preparation of XPP and its homologues with less harmful materials. BRIEF SUMMARY OF THE INVENTION The present invention has found that less expensive alkaline mineralization in the preparation of XPP and its homologues as an acid to reduce a dipolar aprotic solvent, with high or high partial or rapid reaction. Therefore, in one embodiment of the present invention, the preparation of the steric hindrance comprises contacting the sterly hindered chlorophosphate diaryl ester with at least two basic nitrogen-based compounds and when present in the presence of at least one dipolar aprotic solvent as the acid. A specific example is the preparation of a hindered amine comprising diaryl chlorophosphate in contact with at least two basic compounds and in the presence of a dipolar aprotic solvent as an acid acceptor having an amine temperature of at least about 0 °. C, preferably at least about 1 2 〇t:. Please read the note on the back first.
經濟部智慧財產局員工消費合作社印製 合物,二氧化鈣,可 受劑,且同時使用至 地。此舉可使產物產 胺基磷酸酯之方法, 個鹼性N — Η基團之 接受劑之二氧化鈣與 基磷酸酯之方法,包 Ν - Η基團之鹼性氮 之二氧化鈣與至少一 基磷酸酯之玻璃轉移 〇 °C,更好爲至少約 訂 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -5- 1250985 經濟部智慧財產局員工消費合作社印製 Α7 Β7 五、發明說明(3 ) 詳細說明;較佳具體例 於本發明中,位阻胺基磷酸酯爲如下化合物:此化合 物中有至少一個芳基取代基連接到磷雜原子上,且芳族環 上有至少一個取代基相對於芳基一磷雜原子鍵結爲鄰位。 本案方法所用位阻氯磷酸二芳酯具有下式:The Intellectual Property Office of the Ministry of Economic Affairs, the employee consumption cooperative, prints a compound, calcium dioxide, an acceptable agent, and uses it at the same time. The method of producing amino phosphate by a method, a method of treating a calcium oxide and a phosphite of a basic N-fluorene group, and a basic nitrogen-containing calcium dioxide of a ruthenium-hydrazine group At least one phosphatidyl phosphate glass transfer 〇 ° C, preferably at least about the size of the paper, applicable to China National Standard (CNS) A4 specification (210 X 297 mm) -5 - 1250985 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative Α7 Β7 V. DESCRIPTION OF THE INVENTION (3) Detailed Description; Preferred Embodiments In the present invention, a hindered amino phosphate is a compound in which at least one aryl substituent is attached to a phosphorus hetero atom, and At least one substituent on the aromatic ring is ortho to the aryl-phosphorus heteroatom. The hindered bisphosphochlorophosphate used in the method of the present invention has the following formula:
其中A r爲芳基,各R1分別爲院基,芳基或鹵素, Q1爲氧或硫,Q2爲氧,硫或NR1,η爲1至該芳族環 上自由價位置的數目,且該芳族環上至少一個R 1與磷雜原 子鍵結呈鄰位。較好A r爲苯基,η爲1至5。較好各R 1 分別爲一級或二級C i 一 4烷基;更好爲甲基,且η爲2, 各取代基與磷雜原子鍵結呈鄰位。所以較佳胺基磷酸酯爲 氯磷酸二(2,4,6 -三甲苯酯)與氯磷酸二(2,6 一二甲苯酯)。 可使用任何含至少兩個鹼性Ν - Η基團之非環或環狀 化合物。適宜化合物包括具有具有下式者: (II) R2NH-CH2CH2-NHR2 其中各R 2分別爲一級或二級C i 一 4烷基,或者兩個 / R 2合倂爲伸乙基。非環狀化合物的例子爲N,N>-二 甲基乙二胺與Ν,N > —二乙基乙二胺。較好使用雜環化 合物,例子有六氫吡畊與1 ,2,3,4 一四氫喹喏啉’ 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ΤβΤ "Wherein Ar is an aryl group, each R1 is a deutero group, an aryl group or a halogen, Q1 is oxygen or sulfur, Q2 is oxygen, sulfur or NR1, and η is 1 to the number of free valence positions on the aromatic ring, and At least one R 1 on the aromatic ring is ortho to the phosphorus heteroatom bond. Preferably, Ar is a phenyl group and η is from 1 to 5. Preferably, each R 1 is a primary or secondary C i - 4 alkyl group; more preferably a methyl group, and η is 2, and each substituent is ortho to the phosphorus hetero atom bond. Therefore, the preferred amino phosphate is bis(2,4,6-trimethyl chlorophosphate) and bis(2,6-xylylene chlorophosphate). Any acyclic or cyclic compound containing at least two basic hydrazine-hydrazine groups can be used. Suitable compounds include those having the formula: (II) R2NH-CH2CH2-NHR2 wherein each R 2 is a primary or secondary C i -4 alkyl group, or two / R 2 oximes are an exoethyl group. Examples of the acyclic compound are N,N>-dimethylethylenediamine and hydrazine, N >-diethylethylenediamine. It is preferred to use a heterocyclic compound, examples of which are hexahydropyrrole and 1,2,3,4 tetrahydroquinoxaline. The paper size applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) ΤβΤ "
12509851250985
五、發明說明(4 二者=可爲未取代或經取代。最佳爲六氫吡畊。 h ^丨土具體例中,本發明方法可用於製備玻璃轉移 “度爲至少約〇 c ’較好爲至少約丄〇。。,更好爲至少約 2 0 C ’之胺基憐酸酯。本發明方法特別可用於製備式 I I I之fee基憐酸酯: Q1 (III) A2 Q1 , 11 , N-p — a4 A3 經濟部智慧財產局員工消費合作社印製 其中各Q 1分別爲氧或硫;各A 1 — 4分別爲烷氧基,烷 硫基’芳氧基或芳硫基,或是含至少一個烷基或鹵素取代 之方氧基或芳硫基,或其混合物;或爲胺殘基。於本發明 更佳具體例中,各Q :爲氧;各A ^ - 4分別爲2,4,6 一 三甲苯氧基或2 ,6 -二甲苯氧基。這些胺基磷酸酯爲六 氫吡畊型胺基磷酸酯。上式中各Q 1爲氧;各A i — 4分別爲 2,6 -二甲苯氧基之胺基磷酸酯的玻璃轉移溫度爲約 6 2 °C,熔點爲約1 9 2 t:。 於另一較佳具體例中,本發明方法可用於製備玻璃轉 移溫度爲至少約0 °c,較好爲至少約1 〇它,更好爲至少 約2 0 °C,之胺基磷酸酯,其具有式I V :V. Description of the invention (4 Both = can be unsubstituted or substituted. The best is hexahydropyrazine. In the specific case of h ^ bauxite, the method of the invention can be used to prepare glass transfer "degree is at least about 〇c ' Preferably, it is at least about 丄〇, more preferably at least about 20 C' of the amino-pure acid ester. The process of the invention is particularly useful for the preparation of the fe-based pity ester of formula III: Q1 (III) A2 Q1 , 11 , Np — a4 A3 Ministry of Economic Affairs Intellectual Property Office Staff Consumer Cooperatives prints that each Q 1 is oxygen or sulfur; each A 1 - 4 is alkoxy, alkylthio 'aryloxy or arylthio, or a aryloxy or arylthio group substituted with at least one alkyl or halogen, or a mixture thereof; or an amine residue. In a more preferred embodiment of the invention, each Q: is oxygen; each A ^ - 4 is 2, 4,6-trisyloxy or 2,6-xyleneoxy. These amino phosphates are hexahydropyrrole-type amino phosphates. In the above formula, each Q 1 is oxygen; each A i - 4 is The glass transition temperature of the 2,6-xylylene amino phosphate is about 62 ° C and the melting point is about 192 t: In another preferred embodiment, the present invention The process can be used to prepare an amino phosphate having a glass transition temperature of at least about 0 ° C, preferably at least about 1 Torr, more preferably at least about 20 ° C, having the formula I V :
其中各Q 1分別爲氧或硫;各A 5 — 9分別爲烷氧基,烷 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公爱^ ~ "Each of Q 1 is oxygen or sulfur; each A 5 - 9 is alkoxy, and the alkane paper scale is applicable to China National Standard (CNS) A4 specification (210 X 297 public ^^ "
1250985 A7 — B7 五、發明說明(5 ) 硫基,芳氧基或芳硫基’或是含至少一個烷基或鹵素取代 之芳氧基或芳硫基,或其混合物;或爲胺殘基,η爲0至 約5。於更佳具體例中,各Q 1爲氧;各A 5 9分別爲苯氧 基,2 ,6 —二甲苯氧基或2 ,4 ,6 —三甲苯氧基,η 爲0至約5。 於另一較佳具體例中,本發明方法可用於製備玻璃轉 移溫度爲至少約0 °C,較好爲至少約1 〇 °C,更好爲至少 約2 0 t,之胺基磷酸酯,其具有式V : Q11250985 A7 - B7 V. INSTRUCTIONS (5) Thio, aryloxy or arylthio' or an aryloxy or arylthio group substituted with at least one alkyl or halogen, or a mixture thereof; or an amine residue , η is from 0 to about 5. In a more preferred embodiment, each Q 1 is oxygen; each A 5 9 is phenoxy, 2,6-xylyleneoxy or 2,4,6-trimethylphenyloxy, and η is from 0 to about 5. In another preferred embodiment, the process of the invention can be used to prepare an amino phosphate having a glass transition temperature of at least about 0 ° C, preferably at least about 1 ° C, more preferably at least about 20 t, It has the formula V: Q1
經濟部智慧財產局員工消費合作社印製 其中各Q 1分別爲氧或硫;各A 1 13 — 1 5分別爲烷氧基 ,烷硫基,芳氧基或芳硫基,或是含至少一個烷基或鹵素 取代之芳氧基或芳硫基,或其混合物;或爲胺殘基。於更 佳具體例中,各Q1爲氧;各A1()— 15分別爲苯氧基,2 ,6 —二甲苯氧基或2,4,6 —三甲苯氧基。 於另一較佳具體例中,本發明方法可用於製備玻璃轉 移溫度爲至少約0 °c,較好爲至少約1 〇 °c,更好爲至少 約2 0 t,之胺基磷酸酯,其具有式V I : 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -8 - 1250985Each of the Q 1 is oxygen or sulfur, and each of the A 1 13 - 15 is an alkoxy group, an alkylthio group, an aryloxy group or an arylthio group, or at least one An alkyl or halogen substituted aryloxy or arylthio group, or a mixture thereof; or an amine residue. In a more preferred embodiment, each Q1 is oxygen; each A1()-15 is a phenoxy group, a 2,6-xylyleneoxy group or a 2,4,6-trimethyloxy group. In another preferred embodiment, the process of the present invention can be used to prepare an amino phosphate having a glass transition temperature of at least about 0 ° C, preferably at least about 1 ° C, more preferably at least about 20 t. It has the formula VI: This paper scale applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) -8 - 1250985
其中各Q分別爲氧或硫;各A 1 6 1 9分別爲烷氧基 ,k硫基,方氧基或芳硫基,或是含至少一個烷基或鹵素 取代之方氧基或芳硫基,或其混合物;或爲胺殘基;各R 3 分別爲烷基,或者兩個R 3合倂爲伸烷基或烷基取代伸烷基 。於更佳具體例中,各Q 1爲氧;兩個R 3合倂爲未經取代 (c H 2 ) m伸烷基,m爲2至丄〇 ;各A i 6 — i 9分別爲苯 氧基’ 2 ’ 6 — 一甲苯氧基或2 ,4,6 —三甲苯氧基。 於更佳具體例中,各Q1爲氧;各R3爲甲基;各八:6 — 分別爲苯氧基,2 ,6—二甲苯氧基或2 ,4,6 —三甲 苯氧基。 於另一較佳具體例中,本發明方法可用於製備玻璃轉 移溫度爲至少約〇 °c,較好爲至少約1 〇 °c,更好爲至少 約2 0 ° C,之胺基磷酸酯,其具有式v I j : (請先閱讀背面之注意事項再填寫本頁)Wherein each Q is oxygen or sulfur; each A 1 6 1 9 is an alkoxy group, a k-thio group, a aryloxy group or an arylthio group, or a aryloxy group or an aromatic sulfur substituted with at least one alkyl group or a halogen. a group, or a mixture thereof; or an amine residue; each R 3 is an alkyl group, or two R 3 conjugates are an alkylene group or an alkyl-substituted alkylene group. In a more preferred embodiment, each Q 1 is oxygen; two R 3 combined oximes are unsubstituted (c H 2 ) m alkylene, m is 2 to oxime; and each A i 6 — i 9 is benzene Oxy ' 2 ' 6 -monomethyloxy or 2,4,6-trimethyloxy. In a more preferred embodiment, each Q1 is oxygen; each R3 is a methyl group; and each of eight: 6 is phenoxy, 2,6-xyleneoxy or 2,4,6-trimethylphenoxy, respectively. In another preferred embodiment, the process of the present invention can be used to prepare an amino phosphate having a glass transition temperature of at least about 〇 ° C, preferably at least about 1 ° C, more preferably at least about 20 ° C. , which has the formula v I j : (Please read the notes on the back and fill out this page)
經濟部智慧財產局員工消費合作社印製 νπ R4 R6 burR5 γ 式 如 4 R 硫 或 氧 爲 Q 中 其 示 所 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 1250985 A7 B7 五、發明說明(7 ) (VIII)Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed νπ R4 R6 burR5 γ type such as 4 R sulfur or oxygen is Q. The paper scale is applicable to China National Standard (CNS) A4 specification (210 X 297 mm) 1250985 A7 B7 V. INSTRUCTIONS (7) (VIII)
N—X1 —NN—X1 —N
N—乂一N-乂一
一 A22 經濟部智慧財產局員工消費合作社印製 其中各Q 1爲氧或硫;各A 2。— 2 2分別爲烷氧基,院 硫基,芳氧基或芳硫基,或是含至少一個烷基或鹵素取代 之芳氧基或芳硫基,或其混合物;或爲胺殘基;各Z 1分別 爲烷基,芳基或含至少一個烷基或鹵素取代之芳基,或其 混合物;各X 1爲伸烷基,芳基或含至少一個烷基或鹵素取 代之芳基,或其混合物;η爲〇至約5 ; R 5與R 6分別爲 院氧基,院硫基,芳氧基或芳硫基,或是含至少一個院基 或鹵素取代之方氧基或方硫基,或其混合物;或爲胺殘基 。於更佳具體例中,各Q 1爲氧;各A 2 Q - 2 2分別爲苯氧 基,2 ,6 — 一甲苯氧基或2 ,4,6 —三甲苯氧基;各 Z1爲甲基或苯甲基;各X1爲c2 — C24伸烷基;n爲〇 至約5,R 與R 分別爲苯氧基,2,6 -二甲苯氧基或 2,4,6 —三甲苯氧基。 於另一較佳具體例中,本發明方法可用於製備玻璃轉 移溫度爲至少約0 C ’較好爲至少約1 〇 t,更好爲至少 約2 0 °C,之胺基磷酸酯,其具有式;[x : Q1II (IX) R7—P-R9 R8 其中Q1爲氧或硫,R7如式X所示 本紙張尺度適用甲國國豕知準(CNS)A4規格(210 X 297公釐) -10 (請先閱讀背面之注咅3事項再填寫本頁) P-裝-----r---訂---------線 1250985A22 Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed in which each Q 1 is oxygen or sulfur; each A 2 . 2 2 is alkoxy, thiol, aryloxy or arylthio, or an aryloxy or arylthio group substituted with at least one alkyl or halogen, or a mixture thereof; or an amine residue; Each Z 1 is an alkyl group, an aryl group or an aryl group substituted with at least one alkyl group or a halogen group, or a mixture thereof; each X 1 is an alkylene group, an aryl group or an aryl group substituted with at least one alkyl group or halogen. Or a mixture thereof; η is 〇 to about 5; R 5 and R 6 are respectively an oxy group, a thiol group, an aryloxy group or an arylthio group, or a aryloxy group or a group containing at least one of a substituent or a halogen. a thio group, or a mixture thereof; or an amine residue. In a more preferred embodiment, each Q 1 is oxygen; each A 2 Q - 2 2 is phenoxy, 2,6-monomethyloxy or 2,4,6-trimethyloxy; each Z1 is A Or benzyl; each X1 is c2 - C24 alkyl; n is 〇 to about 5, R and R are phenoxy, 2,6-xyleneoxy or 2,4,6-trimethyloxo, respectively base. In another preferred embodiment, the process of the present invention can be used to prepare an amino phosphate having a glass transition temperature of at least about 0 C', preferably at least about 1 Torr, more preferably at least about 20 ° C. Having the formula; [x : Q1II (IX) R7—P-R9 R8 where Q1 is oxygen or sulfur, and R7 is as shown in formula X. The paper size is applicable to the National Standards (CNS) A4 specification (210 X 297 mm). ) -10 (Please read the note on the back 咅 3 items and then fill out this page) P-装-----r---订---------Line 1250985
五、發明說明&V. Invention Description &
經濟部智慧財產局員工消費合作社印製 其中各Q 1爲氧或硫;各x 2分別爲伸烷基或烷基取代 伸院基’芳基或烷芳基;各z 2分別爲伸烷基或烷基取代伸 院基,R 1。,R i :與R i 2分別爲烷氧基,烷硫基,芳氧 基或芳硫基’或是含至少一個烷基或鹵素取代之芳氧基或 芳硫基’或其混合物;或爲胺殘基;η爲0至約5 ; R 8與 R 9分別爲院氧基,烷硫基,芳氧基或芳硫基,或是含至少 一個院基或_素取代之芳氧基或芳硫基,或其混合物;或 爲胺殘基。於更佳具體例中,各Q 1爲氧;各X 2爲伸烷基 或院基取代伸烷基;各ζ 2爲伸烷基或烷基取代伸烷基; R8,R9,R1Q,Rii與Ri2分別爲苯氧基,2,6 — 二甲苯氧基或2 ,4,6 —三甲苯氧基;η爲〇至約5。 於更佳具體例中,各Q i爲氧;各χ 2與Ζ 2爲未經取代( C Η 2 ) m 伸烷基,m 爲 2 至 1 0 ; R 8,R 9,R 1 0, R11與R12分別爲苯氧基,2,6 —二甲苯氧基或2,4 ,6 -三甲苯氧基;η爲〇至約5。特佳具體例中,該胺 基磷酸酯係衍生自六氫吡畊(即,X 2與Ζ 2各爲 -C Η 2 - C Η 2 -)。 於另一較佳具體例中,本發明方法可用於製備玻璃轉 移溫度爲至少約0 °C,較好爲至少約1 0 °c,更好爲至少 (請先閱讀背面之注音?事項再填寫本頁) t· F»裝 訂---------線」 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -11 - 1250985 A7 B7The Intellectual Property Office of the Ministry of Economic Affairs, the Consumers' Cooperatives, prints that each Q 1 is oxygen or sulfur; each x 2 is an alkylene or alkyl substituted alkyl aryl or alkaryl; each z 2 is an alkylene group Or an alkyl substituted pendant, R 1 . , R i : and R i 2 are each an alkoxy group, an alkylthio group, an aryloxy group or an arylthio group 'or an aryloxy group or an arylthio group substituted with at least one alkyl group or a halogen or a mixture thereof; or Is an amine residue; η is from 0 to about 5; R 8 and R 9 are respectively an alkoxy group, an alkylthio group, an aryloxy group or an arylthio group, or an aryloxy group having at least one of a substituent or a phenyl group substituted Or an arylthio group, or a mixture thereof; or an amine residue. In a more preferred embodiment, each Q 1 is oxygen; each X 2 is an alkylene group or a substituted alkyl group; each ζ 2 is an alkylene group or an alkyl substituted alkyl group; R8, R9, R1Q, Rii And Ri2 are phenoxy, 2,6-xylyleneoxy or 2,4,6-trimethyloxy, respectively; η is 〇 to about 5. In a more preferred embodiment, each Q i is oxygen; each of χ 2 and Ζ 2 is an unsubstituted (C Η 2 ) m alkylene group, m is from 2 to 10; R 8, R 9, R 1 0, R11 and R12 are each a phenoxy group, a 2,6-xylyleneoxy group or a 2,4,6-trimethyloxy group; and η is from 〇 to about 5. In a particularly preferred embodiment, the amino phosphate is derived from hexahydropyrazine (i.e., X 2 and Ζ 2 are each -C Η 2 - C Η 2 -). In another preferred embodiment, the method of the present invention can be used to prepare a glass transition temperature of at least about 0 ° C, preferably at least about 10 ° C, more preferably at least (please read the phonetic transcription on the back side; This page) t· F»binding---------line" This paper size applies to China National Standard (CNS) A4 specification (210 X 297 mm) -11 - 1250985 A7 B7
i、發明說明6 ) 約2 〇 t,之環狀胺基磷酸酯,其具有式X I R16 (XI)i. Description of the invention 6) A cyclic amino phosphate of about 2 〇 t, having the formula X I R16 (XI)
〇〇
Q1 II p —A23 (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製 其中各R 1 3 — 1 6分別爲氫或烷基,X 3爲伸烷基,Q 1 爲氧或硫,A 2 3係衍生自一級或二級胺的基團,此胺具有 脂族,脂環,芳族或烷芳族之相同或互異的基團,或A 2 3 係衍生自雜環胺的基團,或A 2 3爲肼化合物。較好Q 1爲 氧。應注意當η爲〇時,該位置上有兩個芳族環以單鍵相 聯(即,X 3不存在)而與磷醯鍵呈鄰,鄰 > 位置。 於另一較佳具體例中,本發明方法可用於製備玻璃轉 移溫度爲至少約0 °C,較好爲至少約1 0 °C,更好爲至少 約2 0 °C,之二環胺基磷酸酯,其具有式X I I : 線“ 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) _ 12 _ 1250985Q1 II p —A23 (Please read the notes on the back and fill out this page.) The Ministry of Economic Affairs, Intellectual Property Office, and the Consumer Cooperatives, print that each of R 1 3 — 16 is hydrogen or alkyl, and X 3 is alkyl. Q 1 is oxygen or sulfur, and A 2 3 is a group derived from a primary or secondary amine having the same or different groups of aliphatic, alicyclic, aromatic or alkane aromatic groups, or A 2 3 It is a group derived from a heterocyclic amine, or A 2 3 is an anthracene compound. Preferably, Q 1 is oxygen. It should be noted that when η is 〇, there are two aromatic rings at this position which are linked by a single bond (i.e., X 3 does not exist) and are adjacent to the phosphonium bond, adjacent > position. In another preferred embodiment, the process of the invention can be used to prepare bicyclic amine groups having a glass transition temperature of at least about 0 ° C, preferably at least about 10 ° C, more preferably at least about 20 ° C. Phosphate ester, which has the formula XII: line "This paper scale applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) _ 12 _ 1250985
、發明說明(10, invention description (10
ο 其中Q1爲氧或硫;各R 爲伸烷基;m與η各爲0或1 一 2ο where Q1 is oxygen or sulfur; each R is an alkylene group; m and η are each 0 or 1 - 2
爲 請 先 閱 讀 背 面 之 注 意 事 項 Μ 本 頁Please read the back of the note first Μ this page
A 經濟部智慧財產局員工消費合作社印製 G1— n — Z3 其中G 爲硫’伸院基’院基取代伸院基’方基或院芳 基;各Z 3分別爲烷基,芳基或是含至少一個烷基或鹵素取 代之芳基,或其混合物;或A 2 4爲 G2 / \ 一 Y2 其中G 2爲伸烷基,芳基或烷芳基;Y 2爲伸烷基或烷 基取代伸院基。較好之胺基憐酸醋爲其Q 1爲氧,A 爲 六氫吡啡之殘基,且此胺基磷酸酯具有通過A 2 4之對稱平 面。更好之胺基磷酸酯爲其Q 1爲氧;A 2 4爲六氫吡畊之 殘基,且此胺基磷酸酯具有通過A 2 4之對稱平面,各芳族 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -13- A7A Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printed G1—n — Z3 where G is the sulphur 'extension base' hospital base instead of the extension base 'square base or courtyard aryl; each Z 3 is alkyl, aryl or Is an aryl group substituted with at least one alkyl group or halogen, or a mixture thereof; or A 2 4 is G2 / \ a Y2 wherein G 2 is an alkylene group, an aryl group or an alkylaryl group; Y 2 is an alkylene group or an alkyl group The base replaces the base. A preferred amine based vinegar is that Q 1 is oxygen, A is a residue of hexahydropyridin, and the amino phosphate has a plane of symmetry through A 2 4 . A better amino phosphate is Q 1 is oxygen; A 2 4 is a residue of hexahydropyrroline, and the amino phosphate has a plane of symmetry through A 2 4, and each aromatic paper scale is applicable to the Chinese country. Standard (CNS) A4 size (210 X 297 mm) -13- A7
1250985 五、發明說明(n ) &上至少一個R取代基爲甲基,且與氧取代基相鄰;η與 m各爲1 ; Χ4爲chr25,其中R25爲氫或ci 6烷基 應注思g η爲〇時,該位置上有兩個芳族環以單鍵相聯 (即’ X4不存在)而與磷醯鍵呈鄰,鄰,位置。 本方法亦可用於製備具有中等玻璃轉移溫度之胺基磷 I酉胃’即使用各種取代或未經取代芳基部分。 依本發明’可用於製備胺基磷酸酯之酸接受劑與溶劑 爲一氧化鈣與偶極非質子溶劑,如二甲基甲醯胺,二甲基 乙_胺,二甲亞硕,砸聯(sulfolane ),六甲基磷醯胺與 N -甲基吼咯烷酮。二甲基甲醯胺通常爲較佳偶極非質子 溶劑’因爲其價格較便宜。其他溶劑,包括但不限於,氯 仿’二氯甲烷或甲苯,可與偶極非質子溶劑混合使用,其 使用有時對產率有助益。較好於反應混合物中排除水。 本發明方法一般於約2 0 - 1 〇 〇 °C時進行,較好約 2 0 - 6 0 °C。較好使用惰性氛圍,如氮氣或氬氣。可以 使用各種方法來摻合試劑。較好酸接受劑,溶劑與鹼性氮 系化合物係依序加入或三者同時加入。 氯磷酸二芳酯與鹼性氮系化合物的莫耳比爲約2 . 0 —2.5:1;較好爲 2. 0 5 — 2.2:1。二氧化鈣 以至少化學計量作爲酸接受劑,即二氧化鈣與氯磷酸二芳 酯的莫耳比爲約0 . 5 — 1 . 0 : 1 ,因爲二氧化鈣爲二 價。偶極非質子溶劑通常佔全部溶劑的約1 5 — 1 0 0體 積%。 反應的進行可以業界公認分析方法來監看。通常 請 先 閱 注 意 事 項 本 頁 經 濟 部 智 慧 財 產 局 員 工 消 費 合 作 社 印 製 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -14- 1250985 A7 ----- B7 五、發明說明(12 ) 〇,5 - 1 5小時爲反應有效完成所需。然後以習知操作 將胺基磷酸酯單離出來。 本發明之產率與習知以三乙胺作爲酸接受劑所得者相 當。 本發明以下列實例來例示。 實例1 取一 5 OmL三頸瓶,裝上機械攪拌器與連接至氮氣 源的冷凝管,於氮氣下添加86〇mg (10mm〇 1) 六氫吡畊,5 6 0 m g ( 1 0 m m ο 1 )無水二氧化鈣, 5〇mg鄰聯三苯(內標準品)與2 OmL無水二甲基甲 醯胺。開始攪拌並將6 · 2 0 g ( 2 0 m m ο 1 )氯磷酸 二(2,6 -二甲苯酯)一次加入。反應混合物經定期取 樣至產物組成不再變化。X P P產率爲7 0 · 3 %。 使用三乙胺的對照組得到的X P P產率爲7 0 · 2 % 實例2 於實例1的燒瓶中,於氮氣下添加8 6 0 m g ( 1 〇 mmo 1)六氫吡畊,56〇mg (lOmmo 1)無水 二氧化鈣,5 0 m g鄰聯三苯(內標準品)與2 0 m L無 水氯仿。開始攪拌並將6 · 2 0 g ( 2 0 m m ο 1 )氯磷 6 -二甲苯酯)一次加入。反應混合物攪拌 小時後,發現有1 6 %的X P p轉化率。然後加入 請 先 閱 讀 背 面 之 注 意 事 項 寫 本 頁 經濟部智慧財產局員工消費合作社印製 酸二1250985 V. Inventive Note (n) & at least one R substituent is methyl and adjacent to an oxygen substituent; η and m are each 1; Χ4 is chr25, wherein R25 is hydrogen or ci 6 alkyl When g η is 〇, there are two aromatic rings at this position which are linked by a single bond (ie, 'X4 does not exist) and are adjacent to, adjacent to, the position of the phosphonium bond. The process can also be used to prepare an aminophosphorus having a moderate glass transition temperature, i.e., using various substituted or unsubstituted aryl moieties. According to the invention, the acid acceptor and solvent which can be used for preparing the amino phosphate are calcium oxide and a dipolar aprotic solvent, such as dimethylformamide, dimethylethylamine, dimethyl sulfoxide, and hydrazine. (sulfolane), hexamethylphosphonium and N-methylpyrrolidone. Dimethylformamide is generally a preferred dipolar aprotic solvent because it is less expensive. Other solvents, including but not limited to, chloroform 'methylene chloride or toluene, can be used in admixture with dipolar aprotic solvents, which are sometimes useful for yield. It is preferred to exclude water from the reaction mixture. The process of the present invention is generally carried out at about 20 - 1 Torr ° C, preferably about 20 - 60 ° C. It is preferred to use an inert atmosphere such as nitrogen or argon. Various methods can be used to blend the reagents. A preferred acid acceptor, a solvent and a basic nitrogen compound are added sequentially or three at the same time. The molar ratio of the diaryl chlorophosphate to the basic nitrogen compound is about 2.0 to 2.5:1; preferably 2. 0 5 to 2.2:1. Calcium dioxide is at least stoichiometric as an acid acceptor, i.e., the molar ratio of calcium dioxide to diaryl chlorophosphate is about 0.5 to 1.0: 0 because calcium dioxide is divalent. The dipolar aprotic solvent typically accounts for about 1 5 - 1 0% by volume of the total solvent. The progress of the reaction can be monitored by industry-recognized analytical methods. Usually please read the notes first. This page is printed by the Intellectual Property Office of the Ministry of Economic Affairs. Employees' Consumption Cooperatives Print this paper scale Applicable to China National Standard (CNS) A4 specification (210 X 297 mm) -14- 1250985 A7 ----- B7 V. DESCRIPTION OF THE INVENTION (12) 〇, 5 - 1 5 hours is required for the reaction to be completed efficiently. The amino phosphate is then isolated by conventional procedures. The yield of the present invention is comparable to that obtained with triethylamine as the acid acceptor. The invention is illustrated by the following examples. Example 1 Take a 5 OmL three-necked flask, install a mechanical stirrer and a condenser connected to a nitrogen source, and add 86 〇 mg (10 mm 〇 1) of hexahydropyrazine under nitrogen, 560 mg (1 0 mm ο 1) Anhydrous calcium dioxide, 5 〇 mg of o-triphenyl (internal standard) and 2 OmL of anhydrous dimethylformamide. Stirring was started and 6·20 g (20 m m ο 1 ) of bis(2,6-xylylene chlorophosphate) was added in one portion. The reaction mixture was periodically sampled until the product composition no longer changed. The yield of X P P was 7 0 · 3 %. The XPP yield of the control group using triethylamine was 7 0 · 2 %. Example 2 In the flask of Example 1, 860 mg (1 〇mmo 1) of hexahydropyrazine, 56 〇mg was added under nitrogen ( lOmmo 1) anhydrous calcium dioxide, 50 mg of o-triphenyl (internal standard) and 20 m of anhydrous chloroform. Stirring was started and 6·20 g (20 m m ο 1 ) chlorophosphor-6-xyl ester was added in one portion. After stirring the reaction mixture for an hour, it was found to have a conversion of X P p of 16%. Then join, please read the back of the note. This page is written by the Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperative, Printing Acid II.
L 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -15- 1250985 五、發明說明(13 一甲基甲醯胺,再攪拌3 0分鐘。分析得知X p p產率爲 8 〇 · 4 %。 典型具體例係作爲例示所用,前述說明與實例並非用 來限制本發明。所以在不背離本發明精神與範圍下,熟習 此技藝人士可有各種變化。L The paper size is applicable to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) -15- 1250985 V. Description of the invention (13-methylformamide, stirring for another 30 minutes. Analysis of X pp yield The present invention is intended to be illustrative, and is not intended to limit the scope of the invention.
閱 讀 背 面 之 注 意 事 項 填·· f裝 本_ 頁IRead the back of the note. Filled with · f loaded this _ page I
I I訂 • I I 線 經濟部智慧財產局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -16-I I Order • I I Line Ministry of Economic Affairs Intellectual Property Bureau Staff Consumer Cooperative Print This paper scale applies to China National Standard (CNS) A4 specification (210 X 297 mm) -16-
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13575599P | 1999-05-25 | 1999-05-25 | |
US09/511,561 US6191276B1 (en) | 1999-05-25 | 2000-02-23 | Method for preparing sterically hindered phosphoramidates |
Publications (1)
Publication Number | Publication Date |
---|---|
TWI250985B true TWI250985B (en) | 2006-03-11 |
Family
ID=26833626
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW089119261A TWI250985B (en) | 1999-05-25 | 2000-09-19 | Method for preparing sterically hindered phosphoramidates |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI250985B (en) |
-
2000
- 2000-09-19 TW TW089119261A patent/TWI250985B/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dembech et al. | The electrophilic amination of carbanions: an unconventional new entry to C− N bond formation | |
KR101550581B1 (en) | Method for buffering a chemical or biological composition | |
PT1924574E (en) | Process for the syntesis of 5-(methyl-1h-imidazol-1-yl)-3-(tri fluorome th yl)-benzeneamine | |
US20030236400A1 (en) | Heteroatom-substituted porphyrins and methods for synthesis of same | |
JPS6272693A (en) | Manufacture of n-substituted aminomethylphosphonic acid | |
KR100311560B1 (en) | Method for preparing aza macrocyclic or acyclic aminophosphonate ester derivatives | |
TWI250985B (en) | Method for preparing sterically hindered phosphoramidates | |
JPH05500949A (en) | Gem-diphosphonic acid, its production method, and pharmaceutical compositions containing the same | |
KR20070067163A (en) | Process for the preparation of pyrazoles | |
KR101970382B1 (en) | Method for producing phosphoric acid ester amides | |
DE60009117T2 (en) | WATER-FREE MIRTAZAPINE CRYSTALS AND A METHOD FOR THEIR PRODUCTION | |
Hoffmann et al. | B12H11-containing guanidinium derivatives by reaction of carbodiimides with H3N–B12H11 (1−). A new method for connecting boron clusters to organic compounds | |
KR100723982B1 (en) | Method for preparing sterically hindered phosphoramidates | |
CA1224896A (en) | Preparation of polyalkyline polyamines using phosphorus amide catalyst | |
EP0730616B1 (en) | Process for preparing polyazamacrocycles | |
US4353830A (en) | Process for the preparation of substituted amidines | |
SU493067A3 (en) | The method of obtaining phenylimidazolidinone | |
JP3067845B2 (en) | Method for producing N-alkylsulfonylaminosulfonylurea | |
SI9200165A (en) | Process for the preparation of pure n,n'-asymmetrically substituted phenylureas | |
ES2952567T3 (en) | Method for preparation of Carsalam | |
US6277988B1 (en) | Solvent-free method for preparing sterically hindered phosphoramidates | |
US4448975A (en) | Process for the preparation of substituted amidines | |
Deprez et al. | Efficient two-step syntheses of sulfonylguanidines from sulfonamides | |
US4548760A (en) | Process for preparing phosphonomethylated amino acids | |
JP3067844B2 (en) | Method for producing N-alkylsulfonylaminosulfonylurea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |